CN Patent

CN107614017A — 肾上腺素制剂

Assigned to Pyle Pharmaceutical Co · Expires 2018-01-19 · 8y expired

What this patent protects

包含肾上腺素的药物组合物、给药方法及其制备方法。组合物可包含活性剂、pH提高剂、抗氧化剂、过渡金属络合剂、pH降低剂、张力调节剂、任选的防腐剂和任选的溶剂中的至少一种。

USPTO Abstract

包含肾上腺素的药物组合物、给药方法及其制备方法。组合物可包含活性剂、pH提高剂、抗氧化剂、过渡金属络合剂、pH降低剂、张力调节剂、任选的防腐剂和任选的溶剂中的至少一种。

Drugs covered by this patent

Patent Metadata

Patent number
CN107614017A
Jurisdiction
CN
Classification
—
Expires
2018-01-19
Drug substance claim
No
Drug product claim
No
Assignee
Pyle Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.